» Articles » PMID: 15121870

Extracellular Signal-regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene Through MafB/Kreisler

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 May 4
PMID 15121870
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular signal-regulated kinase (ERK) facilitates cell cycle progression in most mammalian cells, but in certain cell types prolonged signaling through this pathway promotes differentiation and lineage-specific gene expression through mechanisms that are poorly understood. Here, we characterize the transcriptional regulation of platelet GPIIb integrin (CD41) by ERK during megakaryocyte differentiation. ERK-dependent transactivation involves the proximal promoter of GPIIb within 114 bp upstream of the transcriptional start site. GATA, Ets, and Sp1 consensus sequences within this region are each necessary and function combinatorially in ERK-activated transcription. MafB/Kreisler is induced in response to ERK and synergizes with GATA and Ets to enhance transcription from the proximal promoter. The requirement for MafB in promoter regulation is demonstrated by inhibition of transactivation following dominant-negative or antisense suppression of MafB function. Thus, ERK promotes megakaryocyte differentiation by coordinate regulation of nuclear factors that synergize in GPIIb promoter regulation. These results establish a novel role for MafB as a regulator of ERK-induced gene expression.

Citing Articles

Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation.

Yang Y, Suo N, Cui S, Wu X, Ren X, Liu Y Acta Pharmacol Sin. 2024; 45(12):2527-2539.

PMID: 38871922 PMC: 11579360. DOI: 10.1038/s41401-024-01313-9.


MicroRNA target homeobox messenger RNA in HIV induced hematopoietic inhibition.

Koka P, Ramdass B Front Cell Dev Biol. 2024; 12:1382789.

PMID: 38721526 PMC: 11076784. DOI: 10.3389/fcell.2024.1382789.


Inhibition of MEK/ERK signalling pathway promotes erythroid differentiation and reduces HSCs engraftment in ex vivo expanded haematopoietic stem cells.

Zarrabi M, Afzal E, Asghari M, Mohammad M, Aboulkheyr Es H, Ebrahimi M J Cell Mol Med. 2017; 22(3):1464-1474.

PMID: 28994199 PMC: 5824365. DOI: 10.1111/jcmm.13379.


Association of the Single Nucleotide Polymorphisms in microRNAs 130b, 200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke Mortality.

Kim J, Choi G, Ko K, Kim J, Oh S, Park Y PLoS One. 2016; 11(9):e0162519.

PMID: 27603512 PMC: 5014326. DOI: 10.1371/journal.pone.0162519.


Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion.

Han L, Schubert C, Kohler J, Schemionek M, Isfort S, Brummendorf T J Hematol Oncol. 2016; 9(1):45.

PMID: 27177927 PMC: 4894373. DOI: 10.1186/s13045-016-0275-0.


References
1.
Kelly L, Englmeier U, Lafon I, Sieweke M, Graf T . MafB is an inducer of monocytic differentiation. EMBO J. 2000; 19(9):1987-97. PMC: 305687. DOI: 10.1093/emboj/19.9.1987. View

2.
Visvader J, Crossley M, Hill J, Orkin S, Adams J . The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol. 1995; 15(2):634-41. PMC: 231921. DOI: 10.1128/MCB.15.2.634. View

3.
Motohashi H, Katsuoka F, Shavit J, Engel J, Yamamoto M . Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell. 2001; 103(6):865-75. DOI: 10.1016/s0092-8674(00)00190-2. View

4.
Garcia J, de Gunzburg J, Eychene A, Gisselbrecht S, Porteu F . Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways. Mol Cell Biol. 2001; 21(8):2659-70. PMC: 86897. DOI: 10.1128/MCB.21.8.2659-2670.2001. View

5.
Harada T, Morooka T, Ogawa S, Nishida E . ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol. 2001; 3(5):453-9. DOI: 10.1038/35074516. View